Bristol-Myers, Five Prime Announce Agreement For CSF1R Antibody Program
Bristol-Myers, Five Prime Announce Agreement For CSF1R Antibody Program
View ArticleBristol-Myers, Five Prime to Develop Cancer Treatments
Bristol-Myers, Five Prime to Develop Cancer Treatments
View ArticleFive Prime Therapeutics Inc. (FPRX) Is Up Sharply On Bristol-Myers Agreement
Five Prime Therapeutics Inc. (FPRX) Is Up Sharply On Bristol-Myers Agreement
View ArticleFPRX Awaits Data In Q1, EC Gives Thumbs Up To AMGN''s Kyprolis, Telesta Plunges
FPRX Awaits Data In Q1, EC Gives Thumbs Up To AMGN''s Kyprolis, Telesta Plunges
View ArticleESPR To Provide Clear Details, FPRX' FPA008 Is An Orphan Drug, GTXI On Watch
ESPR To Provide Clear Details, FPRX' FPA008 Is An Orphan Drug, GTXI On Watch
View ArticleAMGN Gets FDA Nod, Data Awaits RGLS In Feb, FORWARD Puts ALKS On The Back Foot
AMGN Gets FDA Nod, Data Awaits RGLS In Feb, FORWARD Puts ALKS On The Back Foot
View ArticleCATB Data Pushed Back To Q1, SMMT At Peak, TRIB Pounded, OTIC Hits Right Notes
CATB Data Pushed Back To Q1, SMMT At Peak, TRIB Pounded, OTIC Hits Right Notes
View ArticleAEZS Disappoints, EVOK Gets New Lease Of Life, GNMX Calls For Attention
AEZS Disappoints, EVOK Gets New Lease Of Life, GNMX Calls For Attention
View ArticleAXON Names New CEO, ANTH Awaits Data In Q3, Nicox Gets 2nd Chance From FDA
AXON Names New CEO, ANTH Awaits Data In Q3, Nicox Gets 2nd Chance From FDA
View ArticleFive Prime's Williams Plans To Transition From CEO To Executive Chairman In 2018
Five Prime's Williams Plans To Transition From CEO To Executive Chairman In 2018
View ArticleGainers & Losers Of Aug.22: OVID, SNNA, BPMC, ABIO, TOCA...
Gainers & Losers Of Aug.22: OVID, SNNA, BPMC, ABIO, TOCA...
View ArticleHIIQ In Good Health, BOLD Awaits ASPIRO Data, CELESTIAL Lights Up EXEL
HIIQ In Good Health, BOLD Awaits ASPIRO Data, CELESTIAL Lights Up EXEL
View ArticleXOMA Shines, PTGX Awaits Data, SELB Implodes, No Stopping NKTR
XOMA Shines, PTGX Awaits Data, SELB Implodes, No Stopping NKTR
View ArticleDEPO Building New Specialty Business, FPRX Rebounds, HALO Glows
DEPO Building New Specialty Business, FPRX Rebounds, HALO Glows
View ArticleEXEL, PFE, ONCE Get FDA Nod, FPRX, ZLAB Team Up, SKLN Soars After Hours
EXEL, PFE, ONCE Get FDA Nod, FPRX, ZLAB Team Up, SKLN Soars After Hours
View ArticleAKAO Faces FDA In June, TECH Opens Wallet, FPRX's FIGHT Begins, TRVN Soars
AKAO Faces FDA In June, TECH Opens Wallet, FPRX's FIGHT Begins, TRVN Soars
View Article